Franklin Genomic Advancements ETF Rating $42.35 -0.76 (-1.76%) As of 10:31 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.79Holdings in HELX have an aggregate rating of Moderate Buy based on 380 analyst ratings issued in the past year covering 22 companies (69.7% of the portfolio).HELX Aggregate Price Target$42.35High Prediction$42.35Average Prediction$42.35Low Prediction$42.35Holdings in HELX have an aggregate price target of $42.35 and a range of $42.35 to $42.35 covering 22 companies (69.7% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HELX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.38%GHGuardant Health$164.91-3.4%3.135 of 5 stars2.96$183.78 11.4%25Positive NewsGap Down8.39%NTRANatera$326.59-1.6%2.5809 of 5 stars2.82$319.38 -2.2%22Positive News5.57%KRYSKrystal Biotech$340.65-1.7%3.9771 of 5 stars2.92$365.40 7.3%13Positive News4.53%ADPTAdaptive Biotechnologies$25.73-1.0%1.4969 of 5 stars2.57$24.42 -5.1%74.24%LGNDLigand Pharmaceuticals$281.02-1.8%3.8265 of 5 stars3.00$335.75 19.5%93.70%BBIOBridgeBio Pharma$81.25-0.3%3.2924 of 5 stars2.83$100.79 24.0%233.54%TWSTTwist Bioscience$139.70-4.0%1.6439 of 5 stars2.70$98.30 -29.6%10Analyst Forecast3.19%UTHRUnited Therapeutics$513.29+0.0%4.231 of 5 stars2.85$646.00 25.9%13Positive NewsInsider Trade2.96%TVTXTravere Therapeutics$65.34-0.6%1.911 of 5 stars2.69$61.67 -5.6%13Positive News2.96%LLYEli Lilly and Company$1,246.88-0.7%4.6991 of 5 stars2.83$1,292.18 3.6%30Trending NewsAnalyst Downgrade2.75%VRTXVertex Pharmaceuticals$547.800.0%4.2097 of 5 stars2.92$563.50 2.9%24Positive News2.47%CTVACorteva$82.58+1.0%4.0581 of 5 stars2.61$91.50 10.8%23Positive News2.31%MEDPMedpace$616.85-0.6%3.5342 of 5 stars2.23$584.18 -5.3%13Positive NewsInsider Trade2.28%REGNRegeneron Pharmaceuticals$829.45-0.6%4.098 of 5 stars2.62$801.70 -3.3%261.65%NBIXNeurocrine Biosciences$153.66+0.7%4.9843 of 5 stars2.88$200.86 30.7%24Positive News1.56%RGENRepligen$182.11+0.5%3.3235 of 5 stars3.00$166.43 -8.6%18Positive News1.54%CRLCharles River Laboratories International$297.40+0.8%1.8584 of 5 stars2.69$255.65 -14.0%161.50%TEMTempus AI$66.99-7.8%1.5634 of 5 stars2.41$65.69 -1.9%17Trending NewsGap Down1.38%PRAXPraxis Precision Medicines$366.98-2.4%2.9907 of 5 stars3.00$585.95 59.7%22Analyst Forecast1.28%CDNACareDx$47.62-2.0%2.981 of 5 stars2.57$47.75 0.3%7Positive News1.27%PTCTPTC Therapeutics$71.30+2.1%3.6051 of 5 stars2.64$98.55 38.2%14Analyst DowngradeInsider Trade1.27%VCYTVeracyte$41.47-2.0%4.381 of 5 stars2.82$54.33 31.0%11Positive News This page (BATS:HELX) was last updated on 8/24/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredEvery UBI experiment has died the same death, except this oneMore than 100 UBI pilots have launched across US cities like Stockton, Denver, and Austin. Nearly all have end...Freedom Financial | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | Sponsored"Second Wave” Hitting Iran Soon? Wall Street Issues WarningAnalysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
